CorMedix Inc.

300 Connell Drive, Suite 4200

Berkeley Heights, NJ 07922

May 20, 2024

VIA EDGAR TRANSMISSION

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Division of Corporation Finance, Office of Life Sciences

Re:	CorMedix Inc.
	Registration Statement on Form S-3
	Filed  May 9, 2024
	File No. 333-279277

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, CorMedix Inc. (the “Company”), hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-279277), so that such registration statement may become effective at 3:00 p.m. (Washington, D.C. time) on May 22, 2024, or as soon as practicable thereafter.

CORMEDIX INC.
By:	/s/ Joe Todisco
	Name: Joe Todisco
	Title: Chief Executive Officer